+39 02 610346.1 - info@newron.com

Latest press releases

  • 30Sep
    Xadago® (safinamide) New Drug Application - Late-Cycle Review Meeting Completed with U.S. FDA


  • 15Sep
    Newron reports half-year 2015 results


  • 14Jul
    Newron Receives FDA Orphan Drug Designation for Sarizotan for the Treatment of Rett Syndrome


  • 25Jun
    Newron receives positive opinion for ODD for Sarizotan to treat patients with Rett Syndrome from EMA’s COMP


  • 15May
    Zambon Launches Xadago® (Safinamide) For Patients With Mid- To Late-Stage Parkinson’s Disease In Germany


  • 30Apr
    Newron Completes CHF24.3M/US$25.5M in Private Placement from Leading EU and US Investors


View All

Newron share price


  • 20Oct
    14th Annual BIO Investor Forum

    October 20-21, 2015 - Parc 55, San Francisco, CA - USA

  • 1Oct
    Investora Zürich 2015

    September 30, October 1, 2015 - ConventionPoint, SIX Swiss Exchange, Zürich - Switzerland

  • 29Sep
    Ladenburg Thalmann 2015 Healthcare Conference

    September 29, 2015 - Sofitel, New York, USA

View Event Calendar